Bortezomib is effective in primary plasma cell leukemia.
Finnegan
Damian P J
DP
Kettle
Paul
P
Drake
Mary
M
Matthews
Christine
C
Alexander
H Denis
HD
Popat
Rakesh
R
Cavanagh
Jamie D
JD
Wachsman
William
W
Morris
T C M
TC
D001856:Bone Marrow Examination; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*; D012074:Remission Induction; D016896:Treatment Outcome
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib